

HY-P99008 · 1 mg
MedChemExpress · Cat: HY-P99008
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/atibuclimab.html
Description
Atibuclimab IC14 , is a chimeric monoclonal antibody directed against CD14 and is composed of murine variable and human IgG4 Fc regions. Atibuclimab attenuates Lipopolysaccharides HY-D1056 LPS -induced symptoms and strongly inhibits LPS-induced proinflammatory cytokine release, while only delaying the release of the anti-inflammatory cytokines soluble TNF receptor type I and IL-1 receptor antagonist. Atibuclimab can be used for the research of amyotrophic lateral sclerosis, sepsis, community-acquired pneumonia, or acute lung injury.







